1. O⁶-Benzylguanine-mediated enhancement of nitrosourea activity in Mer⁻ central nervous system tumor xenografts – implications for clinical trials

   • Stephen T. Keir
   • M. Eileen Dolan
   • Henry S. Friedman

   ORIGINAL ARTICLE Pages: 437 - 440

2. Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK-MAP kinase signal transduction pathway

   • L. Chie
   • S. Amar
   • M. R. Pincus

   ORIGINAL ARTICLE Pages: 441 - 449

3. A comparison of the effects of nine folate analogs on early and late murine hematopoietic progenitor cells in vitro

   • Astrid Strømhaug
   • David J. Warren

   ORIGINAL ARTICLE Pages: 450 - 456

4. Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer

   • M. O. Nicoletto
   • R. Padrini
   • A. Corsini

   ORIGINAL ARTICLE Pages: 457 - 462

5. The pharmacokinetics of a 1-h paclitaxel infusion

   • K. Mross
   • N. Holländer
   • H. Maier-Lenz

   ORIGINAL ARTICLE Pages: 463 - 470

6. In vitro synergistic effects of vinflunine, a novel fluorinated vinca alkaloid, in combination with other anticancer drugs

   • Jean-Marc Barret
   • Chantal Etiévant
   • Bridget T. Hill

   ORIGINAL ARTICLE Pages: 471 - 476

7. Dihydropyrimidine dehydrogenase activity in normal, inflammatory and tumour tissues of colon and liver in humans

   • Rosine Guimbaud
   • Sylvie Guichard
   • Pierre Canal

   ORIGINAL ARTICLE Pages: 477 - 482

8. Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer

   • Ralf Axel Hilger
   • Gabriele Jacek
   • Max Ernst Scheulen

   ORIGINAL ARTICLE Pages: 483 - 488

9. Development of a schedule-dependent population pharmacodynamic model for rhizoxin without quantitation of plasma concentrations

   • Boon C. Goh
   • Gini F. Fleming
   • Mark J. Ratain

   ORIGINAL ARTICLE Pages: 489 - 494

10. The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma

    • Luca Fumagalli
    • Massimo Zucchetti
    • Adriano Lazzarin

    ORIGINAL ARTICLE Pages: 495 - 501

11. New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 production

    • Blair R. McLaren
    • Bruce W. S. Robinson
    • Richard A. Lake

    ORIGINAL ARTICLE Pages: 502 - 508

12. A phase II study of temozolomide in hormone-refractory prostate cancer

    • Jérôme P. van Brussel
    • Martijn B. Busstra
    • Gerald H. Mickisch

    CLINICAL TRIAL REPORT Pages: 509 - 512

13. Ifosfamide and vinorelbine in advanced pretreated ovarian cancer: a phase II study

    • Mario Nardi
    • Salvatore De Marco
    • Francesco Cognetti

    CLINICAL TRIAL REPORT Pages: 513 - 515